Clin2
NCT06710964Possibly a fitNot yet recruiting

Oxytocin and suicide risk study for women ages 18-40

Mechanistic Self-Dehumanization ConditionControl Condition

Treatments studied

Part of Mental health clinical trials.

This study looks at how a hormone called oxytocin might affect suicide risk in women who feel a strong sense of not being fully human (self-dehumanization) and have had suicidal thoughts. You will be asked to fast for 10 hours, have blood drawn, and answer questions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are between 18 and 40 years old.
  • You were born female and have a regular menstrual cycle that lasts 26 to 30 days.
  • You have felt moderately or strongly that you are not fully human (score of 12 or higher on a specific questionnaire).
  • You have had thoughts of suicide at some point in your life.
  • You do not have a fear of needles.
  • You can safely go without food for 10 hours (drinking water is allowed).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06713473Not yet recruiting
Oxytocin nasal spray for suicidal thoughts and feelings of dehumanization

This study tests whether a hormone called oxytocin (given as a nasal spray) can reduce feelings of being less than human and lower suicide risk. Researchers want to see if oxytocin helps people who feel dehumanized and have suicidal thoughts.

Tallahassee, Florida
NCT04923685Recruiting
Study looks at blood markers linked to childhood trauma and suicide risk

This study checks whether tiny genetic signals in blood (microRNAs) are linked to childhood maltreatment and thoughts or risk of suicide, especially in people with major depression. It may help researchers understand biological clues that could someday guide better care.

Birmingham, Alabama
NCT06462196Recruiting
Study of Depression, Bipolar Disorder & Suicide Risk

This study looks at how depression, bipolar disorder, and suicide risk naturally change over time. It aims to better understand these conditions so doctors can improve treatments.

Bethesda, Maryland
NCT05664516Recruiting· Phase 2
Oxytocin treatment study for binge eating disorder adults

This Phase 2 trial tests whether oxytocin (a hormone-like medication) can reduce binge-eating symptoms in adults with binge-eating disorder (including related conditions like bulimia or certain feeding/eating disorders). You may be eligible if your symptoms match the trial’s specific diagnosis rules and you can safely take the study medication.

Boston, Massachusetts
NCT05765864Recruiting
Study of self-harm in at-risk teens

This study looks at self-harm and thoughts/behaviors related to safety in teenagers who are considered at higher risk. It may help researchers better understand what supports are needed for teens who self-harm without wanting to die.

Ljubljana
NCT06222749Recruiting
Oxytocin and Brain Reward in Women

This study looks at how a hormone called oxytocin affects the brain's reward system in women. If you are a healthy woman with a natural menstrual cycle or on birth control pills, you may be able to join and help researchers understand how oxytocin influences emotions and motivation.

Tübingen, Baden-Wurttemberg

Hear when a new Control Condition trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.